In 2020, Indiana’s life sciences companies accessed over $9 billion in capital to grow and support innovation. The funding comes from a variety of sources including Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) awards, venture capital, initial public offerings and related public offerings, and mergers and acquisitions.
BioCrossroads has issued their annual report, Indiana Life Sciences Capital 2020, which provides details on the funding events throughout the year.
